Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tin shielding thicknesses for electrons

S Guru Prasad1, K Parthasaradhi, W H Al-Najjar

  • 1Division of Medical Physics, Northwestern University Medical School, Evanston Hospital, IL 60201, USA.

Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|May 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.

British journal of cancer·2010
Same author

Interaction of strong DNA-intercalating bioreductive compounds with topoisomerases I and II.

Oncology research·2007
Same author

Synergistic interaction between cyclophosphamide or paclitaxel and the bioreductive compound NLCPQ-1, in vivo.

Oncology research·2003
Same author

Therapeutic advantage from combining 5-fluorouracil with the hypoxia-selective cytotoxin NLCQ-1 in vivo; comparison with tirapazamine.

Cancer chemotherapy and pharmacology·2002
Same author

Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia.

International journal of cancer·2001
Same author

In vitro evaluation of 4-[3-(2-nitro-1-imidazolyl)-propylamino]-7-trifluoromethylquinoline hydrochloride (NLTQ-1), a new bioreductive agent as a hypoxia marker by 19F-magnetic resonance spectroscopy (19F-MRS).

In vivo (Athens, Greece)·2001
Same journal

Predictive dosimetric parameters for adaptive replanning in proton beam therapy for thoracic cancer.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same journal

A case study of inhale and exhale split-course VMAT treatment to minimize dose to ribs.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same journal

Prospective clinical implementation of the robust optimization planning technique in long-course photon radiotherapy treatment for lung cancer.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same journal

Dosimetric comparison of target coverage, dose gradient, and low-dose bath in left-sided accelerated partial breast irradiation: CyberKnife versus conventional linac-based noncoplanar VMAT and 3D-CRT.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same journal

Cross-prescription validation of knowledge-based planning in prostate VMAT using a structured validation framework.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same journal

Dosimetric evaluation of beam block techniques in helical tomotherapy for extranodal nasal-type NK/T-cell lymphoma.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
See all related articles

Tin shielding offers advantages for electron beam therapy, producing less harmful radiation than lead. While requiring greater thickness, tin

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Materials Science

Background:

  • Electron beams are used in radiation therapy.
  • Shielding is crucial to protect healthy tissues.
  • Lead is a common shielding material but produces bremsstrahlung.

Purpose of the Study:

  • To compare tin and lead as shielding materials for electron beams.
  • To evaluate the effectiveness of tin in reducing bremsstrahlung radiation.
  • To assess the suitability of tin for organ shielding in radiation therapy.

Main Methods:

  • Transmission measurements of 6-20 MeV electrons through tin and lead.
  • Experiments conducted at 0.5 cm depth in polystyrene.
  • Utilized a 10 x 10 cm2 cone, extending into the bremsstrahlung region.

Related Experiment Videos

Main Results:

  • Tin shielding generates less bremsstrahlung than lead.
  • Tin is a non-toxic alternative shielding material.
  • A thicker tin shield is required compared to an equivalent lead shield.

Conclusions:

  • Tin presents advantages for shielding sensitive organs from electron beams.
  • Tin's lower bremsstrahlung production and non-toxic nature make it a viable option.
  • Further research may optimize tin shielding thickness for clinical applications.